Zussy, C.; John, R.; Urgin, T.; Otaegui, L.; Vigor, C.; Acar, N.; Canet, G.; Vitalis, M.; Morin, F.; Planel, E.;
et al. Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease. Antioxidants 2022, 11, 838.
https://doi.org/10.3390/antiox11050838
AMA Style
Zussy C, John R, Urgin T, Otaegui L, Vigor C, Acar N, Canet G, Vitalis M, Morin F, Planel E,
et al. Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease. Antioxidants. 2022; 11(5):838.
https://doi.org/10.3390/antiox11050838
Chicago/Turabian Style
Zussy, Charleine, Rijo John, Théo Urgin, Léa Otaegui, Claire Vigor, Niyazi Acar, Geoffrey Canet, Mathieu Vitalis, Françoise Morin, Emmanuel Planel,
and et al. 2022. "Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease" Antioxidants 11, no. 5: 838.
https://doi.org/10.3390/antiox11050838
APA Style
Zussy, C., John, R., Urgin, T., Otaegui, L., Vigor, C., Acar, N., Canet, G., Vitalis, M., Morin, F., Planel, E., Oger, C., Durand, T., Rajshree, S. L., Givalois, L., Devarajan, P. V., & Desrumaux, C.
(2022). Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease. Antioxidants, 11(5), 838.
https://doi.org/10.3390/antiox11050838